Navigation Links
Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors
Date:12/13/2008

oad each year. A world leader in research, drug trialing and diagnostics, The Royal Marsden provides inpatient, day care and outpatient services for all areas of cancer treatment.

About Breakthrough Breast Cancer

Breakthrough Breast Cancer is the UK's leading breast cancer charity committed to fighting breast cancer through research, campaigning and education. In 1999 Breakthrough established the UK's first dedicated breast cancer research centre. The Breakthrough Toby Robins Breast Cancer Research Centre is housed in the Mary-Jean Mitchell Green building at The Institute of Cancer Research and was set up in association with the Royal Marsden Hospital in London. The centre is led by Professor Alan Ashworth FRS. For more information about Breakthrough Breast Cancer, please visit http://www.breakthrough.org.uk.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the company's belief that conducting studies in additional patient populations and treatment regimens adds value to the Oncotype DX breast cancer assay, the company's belief that clinical evidence and the results of the study reinforce that Oncotype DX is an indispensable tool when making treatment decisions for node-negative and certain node-positive breast cancer patients, and the conclusions from studies needing additional trials or research and the ability of the company to conduct such studies or research . These risks and uncertainties include, but are not limited to: the results of additional clinical studies; the applicability of clinical study results to actual outcomes; the risk that the company may not obtain sufficient levels of reimbursement for any future tests it may develop; the company's ability to develop and commercia
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Microarray provides 3 genomic guides to breast cancer treatment decisions
3. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
4. Genomic Health to Present at ThinkEquity Partners Fifth Annual Growth Conference
5. Genomic profiling of lung tumors helps doctors choose most effective treatment
6. Genomic technologies to identify toxic chemicals should be developed
7. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
8. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
10. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
11. Genomic Health to Present at JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... (PRWEB) November 26, 2014 Anthropologists ... effectiveness in containing and stopping Ebola, improve international ... in healthcare systems in West Africa. , ... to Stop Ebola: Anthropologists Offer Insights,” will be ... the American Anthropological Association (AAA), Fri., Dec. 5, ...
(Date:11/26/2014)... San Luis Obispo, CA (PRWEB) November 26, 2014 ... bunion treatment, is offering lower prices in an early ... November 26th, Bunion Booties are being offered at the ... Black Friday promotional pricing is in addition to any ... Bootie, visit the Bunion Bootie website for ...
(Date:11/26/2014)... News Facts , Lexmark’s ... RSNA 2014 in Chicago. The company will demonstrate ... images, photos, videos and documents found throughout the ... learn more about these innovative medical content management ... initiatives – that enable more informed clinical decisions, ...
(Date:11/26/2014)... who enter puberty early are at increased risk for ... linked with a number of factors associated with depression, ... to the researchers. Early puberty was also linked to ... and having friends who were prone to getting into ... an association between early puberty and these factors, it,s ...
(Date:11/26/2014)... The number of emergency department visits in the United States ... 136 million in 2011, according to the U.S. Centers for ... fewer people were going to ERs with non-urgent medical needs: ... within two hours of arriving at the ER. In 2010, ... Sixty percent of patients arrived at the ER after normal ...
Breaking Medicine News(10 mins):Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:ER Visits on the Rise, Study Reports 2
... Neurological Disease have now proved using a specialized mouse ... produced by neurons.// The results of this study have ... the two. ,Also known as apoE, this ... apoE4, is the major known genetic risk factor for ...
... Foundation has found that more than 60 percent of people ... food debris// struck in between their teeth. Items like screwdrivers, ... survey said. ,More disturbingly, the survey said that ... rise to oral health problems and bad breath. "Clearly people ...
... is running short of faculty members and its current strength ... ,Replying to a question, minister of state for health ... running with just 479 faculty members as against its sanctioned ... that during 2003-05, 20 faculty members had either resigned or ...
... and Medicaid Services in Baltimore and George Washington University ... who are depressed resort to nursing homes. Depression among ... of the patient. Hence the researchers analyzed the relationship ... surveyed a total of 141,000 seniors. About 13261 of ...
... Although the new government health refoms have cost millions of pounds ... very little benefit for the patients//. ,Cosultants pay and pension ... state that there is no difference to patient care. ... the hospitals. There has been no planning and no guidance on ...
... but still South Africa's own nursing community is faced ... salute the nurses of South Africa and celebrate those ... lives of others in need," said Siphokazi Phillip, international ... Africa (Denosa). ,According to Philip although there ...
Cached Medicine News:Health News:Alzheimer's-linked apolipoprotein E produced by neurons, Gladstone study 2Health News:Nurses in South Africa Face Challenges 2
(Date:11/26/2014)... BOULDER, Colo. , Nov. 25, 2014 ... ARRY ) today announced that its Chief ... speak at the following upcoming conferences.  The ... conferences through webcasts on the Array BioPharma ... ConferenceDate:Wednesday, December 3, 2014Time:1:30 p.m.  Eastern Time ...
(Date:11/26/2014)... 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, ... Dr. Helen Torley , President and Chief Executive ... will be webcast through the "Investors" section of Halozyme,s corporate ... made available for 90 days following the event. To access ...
(Date:11/24/2014)... Juno Therapeutics today announced that the ... company,s JCAR015 chimeric antigen receptor product candidate.  The ... refractory B-cell acute lymphoblastic leukemia and was filed ... Center, where Phase 1 clinical trials are currently ... important news for patients who may benefit from ...
Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3
Intended for the quantitative determination of gammaglutamyl transferase activity in serum or plasma. Single vial, dry powder reagent. Readily soluble at room temperature. Reaction: Kinetic. Waveleng...
Intended for the quantitative determination of calcium in serum. Endpoint Reaction. Reaction complete within one minute, color developed is stable for 30 minutes. Wavelength: 570 nm. Linearity: 16 mg...
For the quantitative determination of alanine aminotransferase in serum used in routine examination and monitoring of therapy and relapses....
For the quantitative determination of Alanine Aminotransferase in serum. Optimized IFCC without P-5'-P, Linearity: 500 IU/L at 37 C. Liquid Working Reagent prepared with simple 1:9 dilution....
Medicine Products: